Astrana Health Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Astrana Health hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

n/a

Ausschüttungsquote

Durchschnittlicher Branchenertrag	1.8%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	US$1.28
Erwartete Dividendenrendite in 3 Jahren	0.4%

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Jun 19

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

Jun 02

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 09

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

Apr 15

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Feb 25

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Feb 07

Apollo Medical Holdings: Good Company, Not Quite A Hold

Jan 17

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Dec 27

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Apr 20

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Mar 21

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Jan 06

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Dec 16

Apollo Medical to acquire Valley Oaks Medical Group

Oct 05

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

Sep 26

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Sep 21

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

Sep 06

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Aug 22

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Aug 04

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Aug 04

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

May 17

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Manage Its Debt With Ease

May 02

Do Apollo Medical Holdings's (NASDAQ:AMEH) Earnings Warrant Your Attention?

Apr 17

Apollo Medical: A Novel HealthTech Company Leading The Digital Revolution

Mar 22

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von ASTH in der Vergangenheit stabil geblieben ist.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von ASTH gestiegen sind.

Dividendenrendite im Vergleich zum Markt

Astrana Health Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von ASTH im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (ASTH)	n/a
Untere 25 % des Marktes (US)	1.5%
Markt Top 25 % (US)	4.8%
Branchendurchschnitt (Healthcare)	1.8%
Analystenprognose in 3 Jahren (ASTH)	0.4%

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von ASTH im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von ASTH im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von ASTH, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da ASTH keine Ausschüttungen gemeldet hat.

Astrana Health Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

Recent updates

Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?

Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal

New minor risk - Shareholder dilution

Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Astrana Health, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Astrana Health, Inc. to Report Q1, 2024 Results on May 07, 2024

Astrana Health, Inc., Annual General Meeting, Jun 12, 2024

Astrana Health, Inc. Announces Redesignation of Albert Young from Chief Administrative Officer to A New Role as Senior Vice President of Health Affairs

Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)

New minor risk - Shareholder dilution

Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

Apollo Medical Holdings, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Apollo Medical Holdings, Inc. Announces Management Changes

Apollo Medical Holdings: Good Company, Not Quite A Hold

With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For

Investor sentiment improves as stock rises 16%

Third quarter 2023 earnings: EPS exceeds analyst expectations

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $100 million worth of its shares.

Apollo Medical Holdings, Inc. Revises Earnings Guidance for the Year Ending December 31, 2023

Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled

Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?

Apollo Medical Holdings, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet

Now 20% undervalued

Apollo Medical Holdings, Inc. Reiterates Earnings Guidance for the Year Ending December 31, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down

Apollo Medical Holdings, Inc. to Report Q2, 2023 Results on Aug 07, 2023

A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire Assets of Texas Independent Providers, LLC.

We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Medical Holdings, Inc. Provides Earnings Guidance for the Year 2023

Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher

Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Investor sentiment improves as stock rises 16%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apollo Medical Holdings, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Apollo Medical Holdings, Inc. Announces Resignation of Michael Eng as Board of Directors, Effective February 15, 2023

Investor sentiment improved over the past week

Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $50 million worth of its shares.

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) announces an Equity Buyback for $50 million worth of its shares.

Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?

President exercised options to buy US$2.9m worth of stock.

Apollo Medical Holdings, Inc. Appoints John Vong as Chief Accounting Officer

Chief Administrative Officer exercised options to buy US$1.6m worth of stock.

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Apollo Medical Holdings, Inc. Revises Earnings Guidance for the Full Year 2022

Apollo Medical Holdings, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Investor sentiment deteriorated over the past week

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire Valley Oaks Medical Group.

Apollo Medical to acquire Valley Oaks Medical Group

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) entered into a definitive agreement to acquire All American Medical Group / For Your Benefit, Inc.

Apollo Medical Holdings, Inc. (NasdaqCM:AMEH) agreed to acquire 100% of All American Medical Group/For Your Benefit, Inc./as well as certain related managed care assets.

Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan

A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)

The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising

With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case

Apollo Medical Holdings, Inc. Reiterates Earnings Guidance for the Year 2022

Second quarter 2022 earnings released: EPS: US$0.25 (vs US$0.29 in 2Q 2021)

Now 21% undervalued

Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance

Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?

Investor sentiment improved over the past week

Apollo Medical Holdings, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Investor sentiment improved over the past week

Apollo Medical Holdings, Inc.(NasdaqCM:AMEH) dropped from Russell Microcap Index